Etiology of febrile neutropenia episodes among cancer patients from Hospital Clinico Universidad Catolica, Santiago-Chile;Etiología de episodios de neutropenia febril en pacientes adultos con cáncer hematológico y de órganos sólidos en el Hospital Clínico Universidad Católica, Santiago-Chile

Revista Chilena de Infectologia

Volumn 26, Issue 2, 2009, Pages 106-113

  Rabagliati B, Ricardo ^a   Fuentes L, Gino ^b   Orellana U, Eric ^a   Oporto C, Jorge ^b   Domínguez M, Isabel ^a   Benítez G, Rosana ^a   Aedo C, Igor ^b   Ramos G, Germán ^a   Garrido S, Marcelo ^b   García C, Patricia ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Cancer; Chemotherapy; Etiology; Infections; Neutropenia

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDIASIS; CHILE; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; FEVER; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HOSPITALIZATION; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; NEOPLASM; NEUTROPENIA; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CANDIDIASIS; CHILE; FEMALE; FEVER; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 67651150084     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Dale D C. Colony-stimulating factors for the management of neutropenia in cancer patients. Drugs 2002; 62: S1-15.
2. Pizzo P A, Robichaud K J, Wesley R, Commers J R. Fever in the pediatric and young adult patient with cancer: A prospective study of 1001 episodes. Medicine 1982; 61: 153-65.
3. Wisplinghoff H, Seifert H, Wenzel R P, Edmond M B. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003; 36: 1103-10.
4. Hughes W T, Armstrong D, Bodey G P, Bow E J, Brown A E, Calandra T, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-51.
5. Marchetti O, Calandra T. Infections in neutropenic cancer patients. Lancet 2002; 359: 723-5.
6. Bochud P Y, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med 1994; 97: 256-64.
7. Yadegarynia D, Tarrand J, Raad I, Rolston K. Current spectrum of bacterial infections in patients with cancer. Clin Infec Dis 2003; 37: 1144-5.
8. Puga B, Puga I, Cabrera M E, Undurraga M S, Guerra C, Urrejola G, et al. Neutropenia febril de alto riesgo en leucemia aguda. Experiencia en un hospital público: Programa Nacional de Drogas Antineoplásicas del Adulto (PANDA), Hospital del Salvador, 1991-2001. Rev Méd Chile 2003, 131: 1023-30.
9. Santolaya M E, Rabagliati R, Bidart T, Paya E, Guzmán A M, Morales R, et al. Consenso: Manejo racional del paciente con cáncer, neutropenia y fiebre. Rev Chil Infect 2005; 22: S79-113.
10. WHO handbook for reporting the results of cancer treatment. WHO Offset Publications, Geneva 1979; Series number 48.
11. García P, Benítez R, Lam M, Salinas A M, Wirth H, Espinoza C, et al. Coagulase-negative staphylococci: clinical, microbiological and molecular features to predict true bacteraemia. J Med Microbiol 2004; 53: 67-72.
12. Ramos G, Domínguez I, Benítez R, Guzmán A M, García P, Sánchez T, et al. Etiología de bacteriemias en neutropenia febril de pacientes adultos con cáncer. Hospital Clínico Universidad Católica 2001- 2004. XXI Congreso Chileno de Infectología. Viña del Mar 13-16 de octubre 2004. Libro de Resúmenes. Pág 42, resumen CO1.
13. Vencer S, Salepci T, Ozer A. Evaluation of infectious etiology and prognostic risk factors of febrile episodes in neutropenic cancer patients. J Infect 2003; 47: 65-72.
14. Toussaint E, Bahel-Ball E, Vekemans M, Georgala A, Al-Hakak L, Paesmans M, et al. Causes of fever in cancer patients (prospective study over 477 episodes) Support Care Cancer 2006 14: 763-9.
15. Klastersky J, Ameye L, Maertens J, Georgala A, Muanza F, Aoun M, et al. Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 2007; 30: S51-9.
16. Bodey G P. Unusual presentations of infection in neutropenic patients. Intl J Antimicrob Agents 2000; 16: 93-5.
17. Klastersky J. Science and pragmatism in the treatment and prevention of neutropenic infection. J Antimicrob Chemother 1998; 41: 13-24.
18. Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 2004; 39: S25-31.
19. Cordonnier C, Buzyn A, Leverger G, Herbrecht R, Hunault M, Leclercq R, et al Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 2003; 36: 149-58.
20. Engelhard D, Elishoov H, Strauss N, Naparstek E, Nagler A, Simhon A, et al Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter: A 5-year prospective study. Transplantation 1996; 61: 430-4.
21. Maschmeyer G, Braverny I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis 2000; 19: 915-25.
22. Rolston K V, Tarrand J J. Pseudomonas aeruginosa-still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center. Clin Infect Dis 1999; 29: 463-4.
23. Rolston K V. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia. Clin Infect Dis 2005; 40: S246-52.
24. García P, Rubilar C, Vicentini D, Labarca J. Caracterización clínica de las bacteriemias por enterobacterias productoras de β;-lactamasas de espectro extendido en un hospital universitario. XXIV Congreso Chileno de Infectología. Pucón 14-17 de noviembre 2007. Libro de Resúmenes. Pág 70, resumen P16.
25. Sipsas N, Bodey G P, Kontoyiannis D P. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer 2005; 103: 1103-13.
26. Cattaneo C, Quaresmini G, Casari S, Capucci M A, Micheletti M, Borlenghi E, et al. Recent changes in bacterial epidemiology and the emergence of fluoroquinolones-resistant Escherichia coli among patient with haematological malignancies: result of a prospective study in 823 patients in a single institution. J Antimicrob Chemother 2008; 61: 721-8.
27. Anaissie E J, Rex J H, Usun O, Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia Am J Med 1998; 104: 238-45.
28. Täger M, Zolezzi P, Folatre I, Navarrete M, Rojas J. Infecciones por virus respiratorios en niños con leucemia linfoblástica aguda y neutropenia febril: Estudio prospectivo. Rev Chil Infect 2006; 23: 118-23.
29. Santolaya M E, Alvarez A M, Avilés C L, Becker A, Cofré J, Enríquez N, et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis 2002; 35: 678-83.
30. Klastersky J, Paesmans M, Rubenstein E B, Boyer M, Elting L, Feld R, et al. The multinational association for supportive care in cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000; 18: 3038-51.
31. Cordonier C, Herbrecht R, Buzyn A, Leverger G, Leclercq R, Nitenberg G et al. Risk factors for gram-negative bacterial infection in febrile neutropenia. Hematologia 2005, 90; 1102-9.
32. Cullen M, Steven N, Billingham L, Gaunt C, Hasting M, Simmonds P et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 2005; 353: 988-98.
33. Freifeld A G, Sepkowitz K A, Almyroudis N G, Segal B H, Castagna L, Santoro A et al. Antibacterial prophylaxis in patients with cancer and neutropenia. N Engl J Med 2006; 354: 90-2.
34. Rabagliati R, Bidart T, Santolaya M E. Uso de profilaxis antibiótica en pacientes neutropénicos. Rev Méd Chile 2006; 134: 801-2.